Fort Bend County reports first measles case in its area
The Brief
Fort Bend County confirmed a measles case in a woman who traveled internationally.
Three cases have been reported in the Houston area.
Excluding Fort Bend County and Houston, 400 measles cases have been reported in Texas.
FORT BEND COUNTY - Fort Bend County has reported its first case of measles in the area.
What we know
According to Fort Bend County Health and Human Services, the case was confirmed in a woman between 50-60 years old who recently traveled internationally.
What we don't know
Health officials tell FOX 26 that the woman's current health condition, where she traveled, and her vaccination status are all under investigation.
What they're saying
"I want to reassure our community that we are working closely with Health and Human Services to keepeveryone informed," said Fort Bend County Judge KP George in a statement. "Your safety and well-being remain my top priority. I urge all residents to check their immunization records, get vaccinated if necessary and stay vigilant for symptoms. Together, we can protect our families, neighbors and the greater Fort Bend community."
The Houston Health Department says it is working to identify Houston residents who may have been exposed to measles in connection to the case in Fort Bend County.
What they're saying
"Our team is working diligently to notify and provide guidance to those who may have been in contact with the individual," said Dr. David Persse, City of Houston's Chief Medical Officer, in a statement. "Measles is highly contagious, but it is also preventable with vaccination."
"Vaccination is the best way to protect yourself, your family and our community," added Dr. Persse. "We strongly encourage anyone who is not fully vaccinated to get their MMR shots as soon as possible."
By the numbers
As of March 16, three measles cases have been confirmed in the Houston area.
All three cases also involved patients who traveled internationally. They were not vaccinated.
The latest Houston case was reported in an infant. The child was last reported to be recovering at home.
RELATED: Infant measles case confirmed as third in Houston this year, officials say
Big picture view
On Friday, March 28, the Texas Department of State Health Services (DSHS) reported 400 total cases of measles across the state since late January 2025. Officials say 41 of those patients have been hospitalized.
The state's outbreak count does not appear to include the cases from Houston.
An outbreak of measles has been reported in Texas' Panhandle and South Plains regions.
The only measles-related death in Texas this year was reported in early February. Lubbock and DSHS officials say a school-age child passed after being hospitalized in Lubbock. The child was not from Lubbock.
Officials say the child was not vaccinated.
RELATED: Texas child becomes first to die of measles in U.S. since 2015
The Source
Fort Bend County Health and Human Services and previous FOX 26 reports.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
8 hours ago
- Yahoo
‘Bobby Kennedy is going to kill more people than any Cabinet secretary': James Carville warns of RFK Jr's vaccine plan
Veteran Democratic strategist James Carville condemned Robert F Kennedy Jr.'s vaccine strategy, cautioning that the Health and Human Services Secretary's policies could have dire outcomes for the nation, including a body count. In an appearance on The Will Cain Show on Fox News, Carville warned: 'Bobby Kennedy is going to kill more people than any Cabinet secretary, maybe in history, with his idiotic vaccine policy.' He added that vaccines are 'the greatest public health intervention in the history of the world,' blasting Kennedy for what he described as fostering distrust in vaccines. 'He has expressed vaccine skepticism at every point,' Carville continued. 'Every notable public health person thinks that vaccines are the greatest public health innovation in the history of the world.' 'What he's doing is going to kill people,' he said, underlining his point. There has been widespread criticism of Kennedy's decision to purge all 17 members of the Centers for Disease Control and Prevention's vaccine advisory panel, citing 'historical corruption.' He then replaced them with a hand-picked panel of eight, whom he said were 'committed to evidence-based medicine, gold-standard science, and common sense,' and who wouldn't be 'ideological anti-vaxxers.' In announcing the new panel, Kennedy noted that each of them has committed to 'demanding definitive safety and efficacy data before making any new vaccine recommendations' and that the committee would review safety and efficacy data for the current schedule. However, the moves have been concerning to experts, who noted that several members have been critical of vaccines. The fired panel members have said that their ousting signaled that scientific expertise was 'no longer of use' under Kennedy and that that decision would 'undermine public trust in the vaccine process,' at a time when vaccine hesitancy has led to the spread of measles and other diseases. The new members are set to meet on June 25 to review safety and efficacy data for the current immunization schedule.
The Hill
12 hours ago
- The Hill
Carville: RFK Jr. ‘is going to kill more people than any Cabinet secretary, maybe in history'
Longtime Democratic strategist James Carville criticized Health and Human Services (HHS) Secretary Robert F. Kennedy Jr.'s vaccine approach, warning the secretary's policies could have fatal consequences for the country. 'Bobby Kennedy is going to kill more people than any Cabinet secretary, maybe in history, with his idiotic vaccine policy,' Carville said Wednesday in an interview on Fox News Channel's 'The Will Cain Show.' Carville added that vaccines are 'the greatest public health intervention in the history of the world,' and blasted Kennedy for what he characterized as sowing distrust in vaccines. 'He has expressed vaccine skepticism at every point,' Carville said. 'Every notable public health person thinks that vaccines are the greatest public health innovation in the history of the world.' 'What he's doing is going to kill people' Carville said of Kennedy. Kennedy has faced criticism for his recent decision to fire all 17 experts on the U.S. Centers for Disease Control and Prevention's (CDC) vaccine panel and replace them with eight of his own picks. The move marked a significant downsizing for the independent, expert panel that provides guidance on vaccine recommendations. Some new advisers have been accused of spreading misinformation about vaccines, but Kennedy has lauded the new team as capable. 'The slate includes highly credentialed scientists, leading public-health experts, and some of America's most accomplished physicians. All of these individuals are committed to evidence-based medicine, gold-standard science, and common sense,' he wrote in a post on X. The new members are set to meet June 25 to review safety and efficacy data for the current immunization schedule. The Hill has reached out to HHS for comment.
American Military News
14 hours ago
- American Military News
RFK Jr. plans crackdown on pharma ads in threat to $10 billion market
The Trump administration is discussing policies that would make it harder and more expensive for pharmaceutical companies to advertise directly to patients, in a move that could disrupt more than $10 billion in annual ad spending. Although the U.S. is the only place, besides New Zealand, where pharma companies can directly advertise, banning pharma ads outright could make the administration vulnerable to lawsuits, so it's instead focusing on cutting down on the practice by adding legal and financial hurdles, according to people familiar with the plans who weren't authorized to speak publicly on the matter. The two policies the administration has focused in on would be to require greater disclosures of side effects of a drug within each ad — likely making broadcast ads much longer and prohibitively expensive — or removing the industry's ability to deduct direct-to-consumer advertising as a business expense for tax purposes, these people said. The discussions are ongoing and plans could still change before the agency undertakes any action, they said. Limiting pharma ads would be a major win for Health and Human Services Secretary Robert F. Kennedy Jr. He's long wanted to more strictly regulate how medicines are promoted. He's said he believes Americans consume more drugs than people in other countries because of the U.S. drug companies' ability to directly advertise to consumers. The new policies could threaten a key source of revenue to advertising and media companies, as well as the U.S. pharmaceutical industry. Companies spent $10.8 billion in 2024 on direct-to-consumer pharmaceutical advertising in total, according to a report from the advertising data firm MediaRadar. AbbVie Inc. and Pfizer Inc. were particularly big spenders. AbbVie alone spent $2 billion on direct-to-consumer drug ads last year, primarily on advertising for the company's anti-inflammatory drugs Skyrizi and Rinvoq. The medicines brought in more than $5 billion for AbbVie in the first quarter of 2025. 'We are exploring ways to restore more rigorous oversight and improve the quality of information presented to American consumers,' HHS spokesperson Andrew Nixon said in a written statement, adding that no final decisions have been made. AbbVie shares fell as much as 2.3% on Tuesday, their biggest drop in a month. Pfizer shares slipped as much as 1.7%. Ad reversal Before the loosening of advertising regulations by the Food and Drug Administration in 1997, U.S. pharma companies had to list all possible side effects for a medication if they wanted to mention which condition the drug being advertised was intended to treat. Reading out a list of side effects took so long it drove up the cost for air time and meant there wasn't as much broadcast advertising as there is today, said Jim Potter, executive director of the Coalition for Healthcare Communication, a trade association. The FDA change allowed ads to disclose fewer side effects and also allowed companies to direct customers to talk to their doctors, call a telephone number, or visit a website to get more information on the advertised drugs. In the following years, TV pharma ad spending surged. In 2024, 59% of the pharmaceutical industry's spend was on television advertising, making pharma the third-highest spending industry on television ads, according to MediaRadar. If the Trump administration brings back some of those restrictions, broadcast ads may become more 'impractical,' according to Meredith Rosenthal, a professor of health economics and policy at Harvard University's school of public health, who has studied the impacts of pharma advertising. More specific drug ads could have benefits for patients who might be prompted to talk to their doctor for the first time about a medical condition like depression or erectile dysfunction, Rosenthal said. However, there are also drawbacks. Drug ads can be used to drive sales of expensive, brand-name medicines when lower-cost generic alternatives may be appropriate, she said. When asked if a crackdown on ads would hurt its business, AbbVie chief commercial officer Jeff Stewart told analysts at a conference in May that the company 'would have to pivot.' He said the company could shift its investment to 'disease awareness' or through advertising on digital channels rather than through mass media. Tax changes The Trump administration could also work with Congress to prohibit pharmaceutical companies from deducting direct-to-consumer advertising costs as business expenses on their taxes. House lawmakers discussed the idea in talks over President Donald Trump's tax cut legislation, but ultimately left the measure out of the bill. The Senate omitted it as well. HHS has been supportive of those discussions, according to a person familiar with the talks. Kennedy has also said publicly he's having conversations about tax changes within the administration, telling Senator Josh Hawley during a May hearing on Capitol Hill that he expected an announcement on the matter 'within the next few weeks.' Joe Grogan, who served as White House Domestic Policy Council chief during President Donald Trump's first term and now consults for health-care companies, said it's unclear whether lawmakers will have an appetite to crack down on the pharmaceutical industry further given Trump's tariff threats and demands to dramatically lower drug prices. Meanwhile, the pharmaceutical industry has warned that allowing lawmakers to regulate advertising by changing the tax code to single out pharmaceutical companies could set a dangerous precedent and raise the specter of lawsuits. Other industries also can deduct advertising costs as business expenses, heightening concerns they could be targeted next. 'If you choose a sector, if one becomes a target, everyone becomes a target,' said Potter of the Coalition for Healthcare Communication. The National Association of Broadcasters, which represents companies that own radio and television stations, said the group opposes restrictions on direct-to-consumer advertising, and that revenue from ads allows local broadcasters to staff newsrooms and invest in weather technology. 'Restricting pharmaceutical ads would have serious consequences for stations, particularly those in smaller markets, and could raise First Amendment concerns,' NAB spokesperson Alex Siciliano said. ___ © 2025 Bloomberg L.P. Distributed by Tribune Content Agency, LLC.
